ClinicalTrials.govpublic full text
Phase l/II Study of Ruxolitinib for Acute Leukemia
leukemia, relapsed acute leukemia, acute myeloid leukemia, aml, acute lymphocytic leukemia, all, ruxolitinib, jakafi, inc424, incb018424, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 866735
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.